Haemonetics Corp (NYSE:HAE)

40.37
Delayed Data
As of Jul 02
 -0.68 / -1.66%
Today’s Change
33.75
Today|||52-Week Range
45.43
+7.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues224.5M227.6M231.8M226.5M
 
 
 
 
 
Cost of Goods Sold97.7M98.4M97.9M96.0M
 
 
 
 
 
Depreciation And Amortization20.5M21.1M22.3M22.2M
 
 
 
 
 
 
Operating ExpensesGross Income106.3M108.1M111.7M108.4M
 
 
 
 
 
General Expenses85.0M80.4M80.5M81.3M
 
 
 
 
 
Research And Development15.4M10.9M10.6M17.2M
 
 
 
 
 
Total Operating Expenses203.2M199.8M200.7M199.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income21.3M27.8M31.2M27.1M
 
 
 
 
 
Extraordinary Credit0.002.8M----
 
 
Extraordinary Charge-23.2M-15.3M-12.9M-15.5M
 
 
 
 
 
Interest Expense On Debt2.3M5.2M2.3M1.9M
 
 
 
 
 
Other Expenses-5.0K-235.0K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.2M9.8M16.0M9.7M
 
 
 
 
 
Income Taxes-560.0K-2.3M-36.0K-12.6M
 
 
 
 
 
Net Income-3.6M7.5M16.0M-2.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.7M51.4M51.4M51.6M
 
 
 
 
 
Shares To Calculate EPS Diluted51.7M51.9M52.0M51.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07$0.14$0.31-$0.06
 
 
 
 
 
EPS Diluted-$0.07$0.14$0.31-$0.06
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account